, Tracking Stock Market Picks
Enter Symbol:
Rating: OMED

Oncomed Pharmaceuticals Inc. (NASDAQ: OMED) rated to Buy by Jefferies

Monday,  Aug 12, 2013  8:25 AM ET by Betsy O'Brien Harrison

Jefferies rated Oncomed
Pharmaceuticals Inc. (NASDAQ: OMED) to Buy.

Jefferiess' research efforts cover U.S. & International equity, high yield, convertibles, derivatives and option strategies, investment grade fixed income, post-reorganization securities, as well as special situations and quantitative research. Our team of more than 150 research professionals covers nearly 1,200 companies in more than 40 industries worldwide. Our analysts focus on identifying emerging industry themes while providing in-depth, thought provoking, objective research.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy